| Bioactivity | Anticancer agent 129 (Compound 3a), a quinoline derivative, predicting to has anti-cancer activity[1]. | ||||||||||||
| Name | Anticancer agent 129 | ||||||||||||
| CAS | 135882-37-0 | ||||||||||||
| Formula | C18H17N3 | ||||||||||||
| Molar Mass | 275.35 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Vaidya A, et al. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach. J Enzyme Inhib Med Chem. 2011 Dec;26(6):854-61. |